Metraipolis › archive › dc_f64f385fc078

Nanoparticles in Vascular Dementia: Advantages and Challenges — Europe PMC PMID:42237946

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42237946
DOI
10.1002/cns.70966
License (as archived)
solo-consultazione
Archived
2026-11-01T01:02:15.068Z
SHA-256 of the archived text
d171c35c633d8c518125c32b4ceba7ec13d33322a7a21274dc997f87b4572ddc
Stable URL of this page
https://metraipolis.com/documento/dc_f64f385fc078

How to cite

Nanoparticles in Vascular Dementia: Advantages and Challenges — Europe PMC PMID:42237946 — Europe PMC (en), https://europepmc.org/article/MED/42237946 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f64f385fc078 (Metraipolis archive dc_f64f385fc078, sha256 d171c35c633d8c518125c32b4ceba7ec13d33322a7a21274dc997f87b4572ddc)
BibTeX
@misc{dcf64f385fc078,
  title = {Nanoparticles in Vascular Dementia: Advantages and Challenges — Europe PMC PMID:42237946},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42237946},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f64f385fc078; sha256 d171c35c633d8c518125c32b4ceba7ec13d33322a7a21274dc997f87b4572ddc},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42237946. Agents can read the archived copy with the MCP tool read_document.